Amplifier Tx
1 known investors
Amplifier TX develops AMPK activators, a class of therapeutics targeting dysfunctional metabolism to treat chronic aging-related diseases. The company focuses on compounds that restore AMPK signaling pathways to improve cellular metabolism and cellular maintenance processes.
BiotechDigital HealthLongevity